Considering dose in pharmacological therapies for heart failure
- PMID: 33485441
- DOI: 10.1016/S0140-6736(21)00089-1
Considering dose in pharmacological therapies for heart failure
Comment in
-
Considering dose in pharmacological therapies for heart failure - Authors' reply.Lancet. 2021 Jan 23;397(10271):275. doi: 10.1016/S0140-6736(21)00090-8. Lancet. 2021. PMID: 33485443 No abstract available.
Comment on
-
Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials.Lancet. 2020 Jul 11;396(10244):121-128. doi: 10.1016/S0140-6736(20)30748-0. Epub 2020 May 21. Lancet. 2020. PMID: 32446323 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
